OMINE Mitsuhiro

J-GLOBAL         Last updated: Jan 29, 2003 at 00:00
 
Avatar
Name
OMINE Mitsuhiro
Affiliation
Showa University
Section
Fujigaoka Hospital, School of Medicine, Internal Medicine
Degree
(BLANK)

Research Interests

 
 

Research Areas

 
 

Education

 
 
 - 
1969
Graduate School, Division of Medical Sciences, The University of Tokyo
 
 
 - 
1964
Faculty of Medicine, The University of Tokyo
 

Misc

 
Deoxyribonucleoside triphosphate metabolism of leukemic cells
Acta Haematologica Japonica   40(6)    1977
Clinical aspects of the Myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB)
Acta haematologica Japonica   52(4)    1989
Characteristic abnormality of deoxyribonucleoside triphosphate metabolism in megaloblastic anemia
Blood   60(4)    1982
Perturbation of leukemic cell population in AKR mice due to chemotherapy
Cancer Research   33    1973
Clinical Implications of Cytokinetic and Biochemical Features of acute leukemia cells
Acta Haematologica Japonica   43(6)    1980

Books etc

 
Acquired hemolytic anemia
Hematology Second edition   1994   
megaloblastic anemia
Standard Textbook of Mternal Medicine   1995   
Hematological disorders
Integrated Handbook of Mternal Mediune   1994   
Platelet dysfunction in myelodysplastic syndrome
Myelodysplastic Syndromes : Advances in Research and treatment (Ed. Nomura T, Yoshida Y) Elsevier. Science (Amsterdam)   1995   
Megaloblastic anemias
1997   

Works

 
Clinicopathology and pathological Chemistry of megaloblastic anemia.
1986
Cliical features, treatment and prognosis of autoimmune hemolytic anemia.
1990
Clinical picture and epidemiology of red cell fragmentation syndrome
1992
A Nation wide survey of clinical features, treatment and prognosis of the red cell fragmentation syndrome
1995
Long-term follow-up study of autoimmune hemolytic anemia
1995

Research Grants & Projects

 
Biochemical aspects of megaloblastic anemia
Biological features of leukemic cells and treatment
Pathophysiology and treatment of hemolytic anemias.